Alejandro Llanes

Centro de Biología Molecular y Celular de Enfermedades, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología AIP (INDICASAT AIP)

Affiliated withInstituto de Investigaciones Científicas y Servicios de Alta Tecnología AIP (INDICASAT AIP)Sistema Nacional de Investigación de Panamá (SNI)

Research Area

Biochemistry

Biography

Alejandro Llanes has not added Biography.
If you are Alejandro Llanes and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 1	2024

Other Publications

Article	Year
The genome of Leishmania panamensis: insights into genomics of the L. (Viannia) subgenus. Scientific reports\| PubMed ID: 25707621	2015
Genome-wide discovery and development of polymorphic microsatellites from Leishmania panamensis parasites circulating in central Panama. Parasites & vectors\| PubMed ID: 26459121	2015
Whole Genome Sequencing Allows Better Understanding of the Evolutionary History of Leptospira interrogans Serovar Hardjo. PloS one\| PubMed ID: 27442015	2016
Use of AFLP for the study of eukaryotic pathogens affecting humans. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases\| PubMed ID: 28935612	2018
Isolation and characterization of serovar Copenhageni from a dog from Saint Kitts. JMM case reports\| PubMed ID: 29188067	2017
Genomic Variability among Field Isolates and Laboratory-Adapted Strains of Serovar Hardjo. International journal of microbiology\| PubMed ID: 29951097	2018
A Marine Diterpenoid Modulates the Proteasome Activity in Murine Macrophages Stimulated with LPS. Biomolecules\| PubMed ID: 30301161	2018
VianniaTopes: a database of predicted immunogenic peptides for Leishmania (Viannia) species. Database : the journal of biological databases and curation\| PubMed ID: 30358842	2018
Peridomestic small Indian mongoose: An invasive species posing as potential zoonotic risk for leptospirosis in the Caribbean. Acta tropica\| PubMed ID: 30465742	2019
High sensitivity and reproducibility of in-house ELISAs using different genotypes of Trypanosoma cruzi. Parasite immunology\| PubMed ID: 30908676	2019
Environmental Conditions May Shape the Patterns of Genomic Variations in . Genes\| PubMed ID: 31652919	2019
Detection and Characterization of Infection and Exposure in Rats on the Caribbean Island of Saint Kitts. Animals : an open access journal from MDPI\| PubMed ID: 32098357	2020
First Whole Genome Sequence of , an Obligate Intracellular Rickettsial Pathogen of Dogs. Pathogens (Basel, Switzerland)\| PubMed ID: 32290349	2020
Genomes: How Genomic Information has been Used to Deal with Past Outbreaks and the COVID-19 Pandemic. International journal of molecular sciences\| PubMed ID: 32604724	2020
Antileishmanial activity of a new chloroquine analog in an animal model of Leishmania panamensis infection. International journal for parasitology. Drugs and drug resistance\| PubMed ID: 32950020	2020
HLA allele and haplotype frequencies in the Panamanian population. Human immunology\| PubMed ID: 33303214	2021
A Computational Approach to Explore the Interaction of Semisynthetic Nitrogenous Heterocyclic Compounds with the SARS-CoV-2 Main Protease. Biomolecules\| PubMed ID: 33375460	2020
Gene expression patterns associated with Leishmania panamensis infection in macrophages from BALB/c and C57BL/6 mice. PLoS neglected tropical diseases\| PubMed ID: 33617537	2021
Epidemiological Aspects of Maternal and Congenital Toxoplasmosis in Panama. Pathogens (Basel, Switzerland)\| PubMed ID: 34204401	2021
Genomic diversity and genetic variation of Leishmania panamensis within its endemic range. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases\| PubMed ID: 35878820	2022
Building Programs to Eradicate Toxoplasmosis Part IV: Understanding and Development of Public Health Strategies and Advances "Take a Village". Current pediatrics reports\| PubMed ID: 35991908	2022
Building Programs to Eradicate Toxoplasmosis Part I: Introduction and Overview. Current pediatrics reports\| PubMed ID: 36034212	2022
Building Programs to Eradicate Toxoplasmosis Part II: Education. Current pediatrics reports\| PubMed ID: 36969368	2022
Building Programs to Eradicate Toxoplasmosis Part III: Epidemiology and Risk Factors. Current pediatrics reports\| PubMed ID: 37744780	2022